Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image_43_0

Top Ten most popular articles on Pharmafile.com this week

December 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, NHS, corruption, lung cancer, opiods crisis, opioids

Corruption and bribery feature heavily in the news this week. A recently exposed 1997 email chain shows Dr Richard Sackler, …

News
novartis_gilenya_multiple_sclerosis_2

FDA approves first three generic versions of Novartis’ Gilenya for relapsing multiple sclerosis

December 6, 2019
Medical Communications, Sales and Marketing Novartis, generics, gilenya, multiple sclerosis, pharma

The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult …

News

Partnership with payers: Communicating and negotiating with impact

December 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma

NDA’s Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team …

News

Amazon and Novartis team up on cloud services

December 5, 2019
Sales and Marketing Amazon Web Services, Cloud services, Novartis, amazon, pharma, product lines

Novartis is teaming up with Amazon Web Services to utilise its cloud computing technology. The collaboration is designed to overhaul …

News
dr-torbett-696x464

Dr Richard Torbett is named as the new Chief Executive of the ABPI

December 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will …

Appointment
332779183_bf240ac640_b

English patient diagnosed with monkeypox after returning from Nigeria

December 5, 2019
Medical Communications Disease, chickenpox, monkeypox

A person has been diagnosed with the rare viral infection monkeypox in South West England. It is believed they contracted …

News
diazepam

Seizures of black market diazepam tablets double in the UK in a year

December 5, 2019
Manufacturing and Production Border Force, Diazepam, NHS, anxiety, opioids

The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 …

News

FDA-approved drug can repair gut leakiness in types of bowel disease

December 5, 2019
Research and Development biomedicine, bowel, bowel cancer, bowel disease

A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis …

News
allergan

Allergan’s ubrogepant doses smash primary endpoints in acute treatment of migraine

December 5, 2019
Research and Development Allergan, FDA, pharma, ubrogepant

New Phase 3 data has been released showing that both 50mg and 100mg doses of Allergan’s ubrogepant met their primary …

News
image3

Patient experience: Living with desmoid fibromatosis

December 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing desmoid fibrosis, feature, patient experience, pharma, rare disease

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis …

Feature
fdaoutsideweb_18

Trump’s new FDA nominee advances in the Senate

December 4, 2019
Research and Development Big Pharma, FDA, FDA commissioner, Trump, US Pharma

Dr Stephen Hahn, President Donald Trump’s FDA nominee, has advanced his nomination to the full Senate chamber. The vote was …

News
contraceptive-pills-849413_960_720

Male birth control drug may hold promise for treating lung cancer, Chinese study finds

December 4, 2019
Research and Development Cancer Immunotherapy, Chinese Pharmaceuticals, Male Birth Control, lung cancer

A drug for male birth control may hold promise for treating lung cancer patients when treatments like immunotherapy do not …

News

FDA approves Johnson & Johnson cataract treatment

December 4, 2019
Research and Development

Johnson & Johnson has secured approval from the FDA for its Tecnis Toris II 1-Piece Intraocular Lens (IOL).                                                                               &nbs

News
tecentriq

Roche’s Tecentriq combo scores FDA approval in non-small cell lung cancer

December 4, 2019
Research and Development, Sales and Marketing FDA, NSCLC, Roche, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atelizumab) has chalked up another approval from the FDA, this time in combination with the chemotherapy Abraxane …

News
920x920

Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show

December 3, 2019
Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis

A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew …

News
astrazeneca_plaque

AstraZeneca sells US/Canada rights for Seroquel for $41 million to “focus on main therapy areas”

December 3, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, pharma

AstraZeneca has announced its intention to jettison the rights to two non-core drugs in the US and Canada in order …

News
showimage

Jeremy Corbyn writes Trump letter asking for reassurance over NHS in trade deal

December 3, 2019
Manufacturing and Production Boris, Boris Johnson, Boris NHS, Jeremy Corbyn, Labour Party, NHS, Trump

Labour Party leader Jeremy Corbyn has written to US President Donald Trump demanding he confirm that he will not put …

News
ap_01101003057-1024x672

Reagan-era FDA Commissioner Frank Young dies

December 3, 2019
Manufacturing and Production FDA, FDA commissioner, Frank Young

Frank Young, FDA Commissioner from 1984-1989, died on 24 November. He was 88; his son, Jonathan, said the cause was …

News

Astellas poised to acquire neuromuscular disease specialist Audentes for $3bn all-cash

December 3, 2019
Manufacturing and Production, Sales and Marketing Astellas, Audentes, acquisition, neuromuscular disease, pharma

Astellas Pharma is set to acquire US-based Audentes Therapeutics in an all-cash deal valued at $3 billion in cash, it …

News

Dr Richard Torbett is named as the new Chief Executive of the ABPI

December 2, 2019
Sales and Marketing British pharmaceuticals, Dr Richard Corbett, apbi, appointments

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025